glutathione fluorescent antibody S-Transferase pi 1/GSTP1 (2G6-F6) Quantitative real-time imaging of glutathione

Research Indicates Skin Tone Improvement

A particularly promising approach involves the rational design of combination therapies that synergistically integrate ferroptosis inducers with emerging immunotherapeutic modalities, such as immune checkpoint inhibitors, chimeric antigen receptor T-cell therapies, or cancer vaccines

38,39 KEY TRIALS IN TARGETING FR Many potential drugs and methods targeting FR in patients are currently under investigation in several phase II and III trials, including monoclonal antibodies, folate-drug conjugates, small molecules, vaccines, and CAR T-cells

We have demonstrated the anti-angiogenic effect of LOX-PP in VEGF mediated angiogenesis, however further studies are warranted to know its function with other angiogenic stimulants